China Resources Medical Holdings Company Limited (1PH) — Cash Flow Quality Index
China Resources Medical Holdings Company Limited (1PH) has a Cash Flow Quality Index of 1.36x as of June 2023. Operating cash flow of €270.22 Million exceeds net income of €198.84 Million, indicating high earnings quality where cash backs reported profits. Explore China Resources Medical Holdings Company (1PH) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China Resources Medical Holdings Company Limited Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for China Resources Medical Holdings Company Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see China Resources Medical Holdings Company operating cash flow efficiency.
Annual Cash Flow Quality Index for China Resources Medical Holdings Company Limited (2017–2025)
Year-by-year earnings quality comparison for China Resources Medical Holdings Company Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.74x | €1.36 Billion | €495.94 Million | ▲ +22.0% |
| 2024 | 2.24x | €1.27 Billion | €565.88 Million | ▼ -51.6% |
| 2023 | 4.64x | €1.20 Billion | €257.68 Million | ▲ +2.9% |
| 2022 | 4.51x | €626.58 Million | €138.97 Million | ▲ +165.2% |
| 2021 | 1.70x | €710.43 Million | €417.92 Million | ▼ -18.1% |
| 2020 | 2.08x | €643.69 Million | €310.13 Million | ▲ +121.6% |
| 2019 | 0.94x | €366.05 Million | €390.87 Million | ▲ +20.8% |
| 2018 | 0.78x | €334.15 Million | €430.90 Million | ▼ -29.0% |
| 2017 | 1.09x | €459.54 Million | €421.03 Million | — |